Mechanisms of oral tolerance by MHC peptides

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 338-345

  Sayegh, Mohamed H ^a   Khoury, Samia J ^b   Hancock, Wayne W ^c   Weiner, Howard L ^b   Carpenter, Charles B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HELPER CELL; IMMUNE SYSTEM; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; INTESTINE EPITHELIUM CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SKIN DEFECT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029991262     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21141.x     Document Type: Article

References (30)

1. KRENSKY, A. M., A. WEISS, G. CRABTREE, M. M. DAVIS & P. PARHAM. 1990. T-lymphocyte-antigen interactions in transplant rejection. N. Engl. J. Med. 322: 510-517.
2. SHOSKES, D. A. & K. J. WOOD. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15: 32-38.
3. SAYEGH, M. H., B. WATSCHINGER & C. B. CARPENTER. 1994. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 57: 1295-1302.
4. BENICHOU, G., A. P. TAKIZAWA, A. C. OLSON, M. MCMILLAN & E. E. SERCARZ. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175: 305-308.
5. FANGMANN, J., R. DALCHAU, G. J. SAWYER, C. A. PRIESTLY & J. W. FABRE. 1992. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur. J. Immunol. 22: 1525-1530.
6. WATSCHINGER, B., L. GALLON, C. B. CARPENTER & M. H. SAYEGH. 1994. Mechanisms of allorecognition: Recognition by in vivo primed T-cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 57: 572-577.
7. GALLON, L., B. WATSCHINGER, B. MURPHY, E. AKALIN, M. H. SAYEGH & C. B. CARPENTER. 1995. Indirect pathway of allorecognition: The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute allograft rejection and its inhibition by conventional immunosuppression. Transplantation 59: 612-616.
8. FANGMANN, J., R. DALCHAU & J. W. FABRE. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175: 1521-1529.
9. AUCHINCLOSS, H. J., R. LEE, S. SHEA, J. S. MARKOWITZ, M. J. GRUSBY & L. H. GLIMCHER. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90: 3373-3377.
10. LEE, R. S., M. L. GRUSBY, L. H. GLIMSHER, H. J. WINN & H. J. AUCHINCLOSS. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179: 865-872.
11. BENHAM, A. M., G. J. SAWYER & J. W. FABRE. 1995. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 59: 1028-1032.
12. SAYEGH, M. H. & M. H. CARPENTER. 1995. Role of indirect allorecognition in allograft rejection. Int. Rev. Immunol. In press.
13. LIU, Z., Y. SUN, Y. XI, A. MAFFEI, E. REED, P. HARRIS & N. SUCIU-FOCA. 1993. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177: 1643-1650.
14. BRAUN, Y. M., A. MCCORMACK, G. WEBB & R. J. BATCHELOR. 1993. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 55: 117-182.
15. SAYEGH, M. H., Z. J. ZHANG, W. W. HANCOCK, C. A. KWOK, C. B. CARPENTER & H. L. WEINER. 1992. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation 53: 163-166.
16. HANCOCK, W. W., M. H. SAYEGH, C. A. KWOK, H. L. WEINER & C. B. CARPENTER. 1993. Oral but not intravenous alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 55: 1112-1118.
17. SAYEGH, M. H., S. K. KHOURY, W. W. HANCOCK, H. L. WEINER & C. B. CARPENTER. 1992. Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc. Natl. Acad. Sci. USA 89: 7762-7766.
18. SAYEGH, M. H., H. L. WEINER & C. B. CARPENTER. 1994. Oral Tolerance. In Pancreatic Islet Transplantation. Volume II: Immunomodulation of Pancreatic Islets. R. P. Lanza & W. L. Chick, Eds.: 153-159. R. G. Landes. Austin, TX.
19. WEINER, H. L., A. FRIEDMAN, A. MILLER, S. J. KHOURY, A. AL-SABBAGH, L. SANTOS, M. H. SAYEGH, R. B. NUSSENBLATT, D. E. TRENTHAM & D. A. HAFLER. 1994. Oral tolerance: Immunologic mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837.
20. FRIEDMAN, A. & H. L. WEINER. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91: 6688-92.
21. KHOURY, S. J., W. W. HANCOCK & H. L. WEINER. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β and prostaglandin E expression in the brain. J. Exp. Med. 176: 1355-1364.
22. CHEN, Y., V. K. KUCHROO, J.-I. INOBE, D. A. HAFLER & H. L. WEINER. 1994. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
23. MILLER, A., O. LIDER & H. L. WEINER. 1991. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 174: 791.
24. HANCOCK, W. W., S. J. KHOURY, C. B. CARPENTER & M. H. SAYEGH. 1994. Differential effects of oral versus intrathymic administration of polymorphic MHC class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am. J. Pathol. 144: 1149-1158.
25. BRANDEIS, J. M., M. H. SAYEGH, L. GALLON, R. S. BLUMBERG & C. B. CARPENTER. 1994. Rat intestinal epithelial cells present major histocompatibility complex allopeptides to primed T cells. Gastroenterology 107: 1537-1542.
26. KRENSKY, A. M. & C. CLAYBERGER. 1994. The induction of tolerance to alloantigens using HLA based synthetic peptides. Curr. Opinion Immunol. 6: 791-796.
27. NISCO, S., P. VRIENS, G. HOYT, S.-C. LYU, F. FARFAN, P. POULETTY, K. A. M. & C. CLAYBERGER. 1994. Induction of allograft tolerance in rats by an HLA class I derived peptide and cyclosporine A. J. Immunol. 152: 3786-3792.
28. SAYEGH, M. H. & A. M. KRENSKY. 1995. Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int. In press.
29. MURPHY, B., E. AKALIN, B. WATSCHINGER, C. B. CARPENTER & M. H. SAYEGH. 1995. Inhibition of the alloimmune response with synthetic non-polymorphic class II MHC peptides. Transplant. Proc. 27: 409-410.
30. SAYEGH, M. H., L. GALLON & C. B. CARPENTER. 1994. Immunomodulating the alloimmune response with synthetic peptides. In New Immunosuppressive Modalities and Anti-rejection Approaches in Organ Transplantation. J. W. Kupiec-Weglinski, Ed.: 155-168. R. G. Landes. Austin, TX.